Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

Not Applicable

Completed

• Conditions: Gastritis
• Interventions: Drug: Weiqi decotion

• Registration Number: NCT00920712
• Lead Sponsor: Shanghai University of Traditional Chinese Medicine

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-06-11
• Study First Submitted QC: 2009-06-12
• Study First Posted: 2009-06-15
• Status Verified: 2009-08
• Study Start: 2009-08
• Primary Completion: 2012-06
• Study Completion: 2012-07
• Last Update Submitted: 2016-04-18
• Last Update Posted: 2016-04-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Clinical diagnosis of Chronic Atrophic Gastritis
• Male of female patients between 18-65 years old
• Written informed consent

Exclusion Criteria

• Combine with malignant pathology on epithelial dysplasia of gastric mucosa
• Combine with duodenal ulcer or gastric ulcer
• Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
• Pregnancy or breast feeding women, or unwilling to have contraception.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Weiqi decoction	Weiqi decotion	-
low dose of Weiqi decoction	Weiqi decotion	-

Primary Outcome Measures

Name	Time	Method
Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change	12 weeks

Secondary Outcome Measures

Name	Time	Method
Indicates of liver and renal function	12 weeks

Trial Locations

Locations (1)

Longhua hospital; 🇨🇳 Shanghai, Shanghai, China